Results 331 to 340 of about 2,734,758 (393)

Chronic liver disease questionnaire to manage patients with chronic liver diseases

Hepatology Research, 2022
AbstractBackground and AimsAlthough patients with chronic liver disease (CLD) usually show few symptoms, they exhibit decreased health‐related QOL (HRQOL) with occurrence complications including hepatocellular carcinoma (HCC). Health‐related QOL is an important indicator in the management of CLD.
Kazuto Tajiri, Yuka Hayashi Futsukaichi, Aiko Murayama, Masami Minemura, Terumi Takahara, Ichiro Yasuda   +5 more
openaire   +2 more sources

Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD

Hepatology, 2020
Chronic hepatitis B virus (HBV), hepatitis C virus (HCV), nonalcoholic fatty liver disease (NAFLD), and alcohol‐associated liver disease (ALD) are main causes of chronic liver disease.
James M. Paik, P. Golabi, Youssef Younossi, A. Mishra, Z. Younossi   +4 more
semanticscholar   +1 more source

Reduced handgrip strength predicts poorer survival in chronic liver diseases: A large multicenter study in Japan

Hepatology Research, 2021
Sarcopenia has a high prevalence and can be an adverse predictor in patients with chronic liver diseases (CLDs). We sought to assess the prevalence of sarcopenia and its prognostic significance in patients with CLDs at multiple centers in Japan.
H. Nishikawa, M. Shiraki, A. Hiramatsu, Nagisa Hara, K. Moriya, K. Hino, K. Koike   +6 more
semanticscholar   +1 more source

Chronic cholestatic liver diseases

Scandinavian Journal of Gastroenterology, 2017
Sir,Chronic cholestatic liver diseases typically comprise primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC), previously called primary biliary cirrhosis.
Helge L, Waldum, Einar S, Björnsson, Eiliv, Brenna   +2 more
openaire   +2 more sources

Mitochondria in Chronic Liver Disease

Current Drug Targets, 2011
Mitochondria are the main energy source in hepatocytes and play a major role in extensive oxidative metabolism and normal function of the liver. This key role also assigns mitochondria a gateway function in the center of signaling pathways that mediate hepatocyte injury, because impaired mitochondrial functions affect cell survival and contribute to ...
GRATTAGLIANO I, RUSSMANN S, DIOGO CV, BONFRATE L, OLIVEIRA PJ, WANG DQ, PORTINCASA, Piero   +6 more
openaire   +3 more sources

Chronic HBV-related liver disease

Molecular Aspects of Medicine, 2008
Thirty years after its discovery, the hepatitis B virus (HBV) still remains a major global public health problem. Worldwide, two billion subjects have been infected, 300 million have a chronic infection and more than 600,000 die annually of HBV-related liver disease or hepatocellular carcinoma; new infections occur because of the presence of a large ...
RIZZETTO, Mario, CIANCIO, Alessia
openaire   +3 more sources

Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases.

Gastroenterology, 2018
Mitochondria regulate hepatic lipid metabolism and oxidative stress. Ultrastructural mitochondrial lesions, altered mitochondrial dynamics, decreased activity of respiratory chain complexes, and impaired ability to synthesize adenosine triphosphate are ...
A. Mansouri, Charles-Henry Gattolliat, T. Asselah   +2 more
semanticscholar   +1 more source

Chronic liver disease

Journal of General Internal Medicine, 2000
To the Editor:—The review by Riley et al.1 of preventive care in patients with chronic liver disease offers a useful outline of the critical elements to be addressed by physicians serving this growing population. The authors appropriately cite the opportunity to prevent exacerbations and optimize the length of time between hepatitis, cirrhosis, and ...
Steven G. Gordon, Thomas R. Riley
openaire   +1 more source